• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促性腺激素受体突变的分子遗传学、生物化学及临床意义

Molecular genetic, biochemical, and clinical implications of gonadotropin receptor mutations.

作者信息

Chan W Y

机构信息

Department of Pediatrics, Georgetown University Children's Medical Center, Washington, DC 20007, USA.

出版信息

Mol Genet Metab. 1998 Feb;63(2):75-84. doi: 10.1006/mgme.1997.2650.

DOI:10.1006/mgme.1997.2650
PMID:9562960
Abstract

Human reproductive function is regulated mainly by luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Mutations of the human LH/ chorionic gonadotropin receptor (LHR) and the FSH receptor (FSHR) leading to either constitutive activation or inactivation of the receptors have been identified. All activating mutations of the LHR and the FSHR are located within the exon encoding the transmembrane domain while the inactivating mutations are scattered throughout the coding sequence. A number of activating and inactivating mutations of the LHR have been found while only one activating and three inactivating mutations of the FSHR are known. Activating mutations of the LHR cause familial male-limited precocious puberty (FMPP) while that of the FSHR has been shown to restore the reproductive capability of a hypophysectomized male. Inactivating mutations of the LHR cause Leydig cell hypoplasia (LCH) in males while that of the FSHR causes hereditary hypergonadotropic ovarian dysgenesis (ODG) in females. Activating mutations of both receptors are dominant while inactivating mutations are recessive. Genotype-phenotype correlation is best established for the inactivating mutations of LHR. Severity of clinical phenotype in LCH correlates with the amount of residual activity of the mutated LHR. Comparison of the clinical impact of the activating and the inactivating mutations of the receptors indicates that male reproductive capacity depends primarily on LH while female reproductive capacity depends primarily on FSH.

摘要

人类生殖功能主要由促黄体生成素(LH)和促卵泡生成素(FSH)调节。已鉴定出人类LH/绒毛膜促性腺激素受体(LHR)和FSH受体(FSHR)的突变,这些突变导致受体的组成性激活或失活。LHR和FSHR的所有激活突变都位于编码跨膜结构域的外显子内,而失活突变则散布在整个编码序列中。已发现许多LHR的激活和失活突变,而已知FSHR只有一个激活突变和三个失活突变。LHR的激活突变导致家族性男性限性性早熟(FMPP),而FSHR的激活突变已被证明可恢复垂体切除男性的生殖能力。LHR的失活突变导致男性睾丸间质细胞发育不全(LCH),而FSHR的失活突变导致女性遗传性高促性腺激素性卵巢发育不全(ODG)。两种受体的激活突变都是显性的,而失活突变是隐性的。LHR失活突变的基因型-表型相关性建立得最好。LCH临床表型的严重程度与突变LHR的残余活性量相关。受体激活和失活突变的临床影响比较表明,男性生殖能力主要取决于LH,而女性生殖能力主要取决于FSH。

相似文献

1
Molecular genetic, biochemical, and clinical implications of gonadotropin receptor mutations.促性腺激素受体突变的分子遗传学、生物化学及临床意义
Mol Genet Metab. 1998 Feb;63(2):75-84. doi: 10.1006/mgme.1997.2650.
2
Inactivating mutations of LH and FSH receptors--from genotype to phenotype.促黄体生成素和促卵泡生成素受体的失活突变——从基因型到表型
Pediatr Endocrinol Rev. 2006 Sep;4(1):28-31.
3
[Inactivating and activating mutations of the human LH/hCG receptor leading to male pseudohermaphroditism and familial male-limited precocious puberty].[导致男性假两性畸形和家族性男性局限性性早熟的人促黄体生成素/人绒毛膜促性腺激素受体的失活和激活突变]
Nihon Rinsho. 2002 Feb;60(2):265-71.
4
Mutations along the pituitary-gonadal axis affecting sexual maturation: novel information from transgenic and knockout mice.垂体-性腺轴上影响性成熟的突变:来自转基因和基因敲除小鼠的新信息。
Mol Cell Endocrinol. 2006 Jul 25;254-255:84-90. doi: 10.1016/j.mce.2006.04.015. Epub 2006 May 30.
5
Molecular cloning and characterization of FSH and LH receptors in Atlantic salmon (Salmo salar L.).大西洋鲑(Salmo salar L.)促卵泡激素(FSH)和促黄体生成素(LH)受体的分子克隆与特性分析
Gen Comp Endocrinol. 2006 Oct;149(1):108-17. doi: 10.1016/j.ygcen.2006.04.011. Epub 2006 Jun 9.
6
Follicle stimulating hormone receptor mutations and reproductive disorders.卵泡刺激素受体突变与生殖障碍。
Prog Mol Biol Transl Sci. 2009;89:115-31. doi: 10.1016/S1877-1173(09)89005-4. Epub 2009 Oct 7.
7
Zebrafish gonadotropins and their receptors: I. Cloning and characterization of zebrafish follicle-stimulating hormone and luteinizing hormone receptors--evidence for their distinct functions in follicle development.斑马鱼促性腺激素及其受体:I. 斑马鱼促卵泡激素和促黄体生成素受体的克隆与特性分析——其在卵泡发育中不同功能的证据
Biol Reprod. 2005 Jun;72(6):1370-81. doi: 10.1095/biolreprod.104.038190. Epub 2005 Feb 23.
8
Luteinizing hormone receptor mutations in disorders of sexual development and cancer.性发育障碍和癌症中的促黄体生成素受体突变
Front Biosci. 2000 Mar 1;5:D343-52. doi: 10.2741/wu.
9
Cloning and sequence analysis of the extracellular region of the polar bear (Ursus maritimus) luteinizing hormone receptor (LHr), follicle stimulating hormone receptor (FSHr), and prolactin receptor (PRLr) genes and their expression in the testis of the black bear (Ursus americanus).北极熊(Ursus maritimus)促黄体生成素受体(LHr)、促卵泡激素受体(FSHr)和催乳素受体(PRLr)基因细胞外区域的克隆与序列分析及其在黑熊(Ursus americanus)睾丸中的表达
Mol Reprod Dev. 2000 Feb;55(2):136-45. doi: 10.1002/(SICI)1098-2795(200002)55:2<136::AID-MRD2>3.0.CO;2-J.
10
Molecular cloning, sequence analysis and expression of the snake follicle-stimulating hormone receptor.蛇促卵泡激素受体的分子克隆、序列分析及表达
Gen Comp Endocrinol. 2004 Jul;137(3):300-11. doi: 10.1016/j.ygcen.2004.03.014.

引用本文的文献

1
Precocious Puberty in Boys: A Study Based on Five Years of Data from a Single Center in Northern China.男孩性早熟:基于中国北方某单一中心五年数据的研究。
J Clin Res Pediatr Endocrinol. 2021 Nov 25;13(4):418-425. doi: 10.4274/jcrpe.galenos.2021.2021.0033. Epub 2021 May 20.
2
How genetic errors in GPCRs affect their function: Possible therapeutic strategies.G蛋白偶联受体(GPCRs)中的基因错误如何影响其功能:可能的治疗策略。
Genes Dis. 2015 Jun;2(2):108-132. doi: 10.1016/j.gendis.2015.02.005.
3
Effect of luteinizing hormone/choriogonadotropin receptor (LHCGR) gene on chicken reproductive traits.
黄体生成素/绒毛膜促性腺激素受体(LHCGR)基因对鸡繁殖性状的影响。
Mol Biol Rep. 2013 Dec;40(12):7111-6. doi: 10.1007/s11033-013-2834-6. Epub 2013 Nov 6.
4
Distinct mechanisms of cAMP induction by constitutively activating LH receptor and wild-type LH receptor activated by hCG.
Endocrine. 2004 Nov;25(2):111-5. doi: 10.1385/ENDO:25:2:111.